Bill
Bill > HB809
PA HB809
PA HB809Further providing for definitions and for prohibited acts and penalties; and providing for syringe service programs authorized.
summary
Introduced
03/05/2025
03/05/2025
In Committee
03/05/2025
03/05/2025
Crossed Over
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for definitions and for prohibited acts and penalties; and providing for syringe service programs authorized.
AI Summary
This bill amends Pennsylvania's Controlled Substance, Drug, Device and Cosmetic Act to expand definitions of drug paraphernalia and establish legal protections for syringe service programs (SSPs) designed to reduce disease transmission and harm among individuals using controlled substances. The bill modifies the definition of drug paraphernalia to specifically exclude syringes and harm reduction supplies provided through authorized programs, and creates a comprehensive framework for establishing SSPs. Key provisions include allowing public and private entities to create SSPs that provide sterile needles, offer referrals for health services, distribute identification cards to participants, and establish safe needle disposal sites. The bill requires SSPs to register annually with the Department of Health, report detailed metrics about their operations, and comply with location restrictions near schools and playgrounds. Additionally, the bill protects SSP participants from prosecution for residual amounts of controlled substances in used syringes and provides legal immunity for program operators in cases without willful misconduct. The Department of Health is tasked with providing oversight, issuing annual reports, and developing best practices guidance for these programs. The legislation aims to reduce health risks associated with drug use by providing structured, supportive intervention strategies.
Committee Categories
Justice
Sponsors (7)
Jim Struzzi (R)*,
Dan Frankel (D),
Roni Green (D),
Tarik Khan (D),
Steve Malagari (D),
Lindsay Powell (D),
Ben Sanchez (D),
Last Action
Referred to Judiciary (on 03/05/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...